21104 ⎘
Medicinal preparations containing antigens or antibodies; Bacterial antigens Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
METHODS FOR PREVENTING THE DEVELOPMENT OF A GASTRIC DISEASE ASSOCIATED WITH HELICOBACTER PYLORI INFECTION WITHOUT ERADICATING THE INFECTION AND FOR THE ASSESSMENT OF THE RISK OF DEVELOPING SUCH DISEASE
#2VACCINE AGAINST CAMPYLOBACTER JEJUNI
#3PREPARATION OF LIVE VACCINES
#4VACCINATION WITH MICA/B ALPHA 3 DOMAIN FOR THE TREATMENT OF CANCER
#5METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS
#6BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS
#7INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION
#8Ferritin Proteins
#9PSORALEN-INACTIVATED NEISSERIA GONORRHOEAE VACCINES AND METHODS THEREOF
#10PREPARATION OF LIVE VACCINES
#11Hyper-Blebbing Bacteria
#12LAWSONIA INTRACELLULARIS COMPOSITIONS AND METHODS OF USING THE SAME
#13Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process
#14IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS
#15COMBINATION PORCINE VACCINE
#16ATTENUATED SALMONELLA SYNTHESIZING ANTIGENS FOR VACCINATING AGAINST HELICOBACTER PYLORI
#17Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process
#18Helicobacter therapeutic
#19LAWSONIA INTRACELLULARIS COMPOSITIONS AND METHODS OF USING THE SAME
#20IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY
#21Preparation of live vaccines
#22METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTIC MICROBIAL THERAPEUTICS
#23Application of Heptoglycan-chain-containing Oligosaccharide Compounds in Preparation of Vaccine against Helicobacter pylori
#24VACCINATION WITH MICA/B ALPHA 3 DOMAIN FOR THE TREATMENT OF CANCER
#25METHOD FOR DIAGNOSING INFECTION WITH HELICOBACTER SUIS
#26Food safety vaccine to control and reduce in poultry
#27Recombinant vaccine against proliferative enteropathy in animals
#28Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production
#29Ferritin proteins
#30Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#31Immunogenic compositions comprising
#32PCV/mycoplasma hyopneumoniae vaccine
#33Campylobacter immunogenic compositions and uses thereof
#34Compositions and methods of enhancing immune responses to enteric pathogens
#35ANTIBODY TO CYTOLETHAL DISTENDING TOXIN OF CAMPYLOBACTER JEJUNI
#36Glycosylation method
#37HELICOBACTER THERAPEUTIC
#38Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process
#39Combination vaccine for swine
#40Vaccines containing swine pathogens for associated non-mixed use
#41Whole cell vaccines
#42Food safety vaccine to control and reduce campylobacter in poultry
#43Recombinant gram negative bacteria and methods of generating and utilizing same
#44Method for reducing skatole and/or indole in animals
#45Compositions and methods of enhancing immune responses to enteric pathogens
#46Immunogenic composition against
#47PCV/vaccine for use with PRRSV vaccine
#48Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production
#49Antibody to cytolethal distending toxin of Campylobacter jejuni
#50Synthetic antigen constructs against campylobacter jejuni
#51Immunogenic compositions comprising
#52A COMBINATION VACCINE AGAINST PCV2 VIRUS AND MYCOPLASMA HYOPNEUMONIAE INFECTION
#53Campylobacter immunogenic compositions and uses thereof
#54Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
#55Combined enteropathogen recombinant construct
#56vaccines
#57Vaccination with MICA/B alpha 3 domain for the treatment of cancer
#58A VACCINE TO PROTECT AN MDA POSITIVE ANIMAL AGAINST A DISORDER ARISING FROM AN INFECTION WITH LAWSONIA INTRACELLULARIS
#59Immunogenic composition against
#60Immunological signatures and parameters predicting therapeutic responses to anti-TNF therapy
#61CAMPYLOBACTER JEJUNI PEPTIDE FOR VACCINE DEVELOPMENT
#62Synthetic antigen constructs against
#63Glycosylation method
#64Vaccine for use against subclinical infection in a pig
#65Vaccine for use against subclinical infection in a pig
#66Combined enteropathogen recombinant construct
#67PCV/mycoplasma hyopneumoniae/lawsonia intracellularis combination vaccine
#68Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins
#69Immunotherapy composition and use thereof
#70HELICOBACTER THERAPEUTIC
#71Vaccine against porcine circo virus type 2
#72Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject
#73Compositions produced using enteric pathogens and methods of use
#74Compositions produced using enteric pathogens and methods of use
#75Compositions produced using enteric pathogens and methods of use
#76Compositions produced using enteric pathogens and methods of use
#77Immunogenic compositions comprising
#78Swine Vaccine Against PRRS and Lawsonia Intracellularis
#79Vaccine against Lawsonia intracellularis and porcine circovirus 2
#80Fish vaccine
#81Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
#82Methods of using presenting N-glycan or derivatives thereof
#83Campylobacter immunogenic compositions and uses thereof
#84Immunotherapy composition and use thereof
#85Peptides derived from Campylobacter jejuni and their use in vaccination
#86Synthetic antigen constructs against
#87Compositions and methods of enhancing immune responses to enteric pathogens
#88Compositions produced using enteric pathogens and methods of use
#89Glycosylation method
#90Effective method of treatment of porcine circovirus and infections
#91Method for treating infections
#92Preparation of live vaccines
#93lipopolysaccharide outer core epitope
#94Immunogenic composition against
#95Vaccine and methods to reduce campylobacter infection
#96Bacterial vaccine
#97Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#98immunogenic compositions and uses thereof
#99Immunogenic compositions comprising
#100Influenza hemagglutinin protein-based vaccines
#101CATIONIC METAL OXIDES FOR USE AS VACCINE ADJUVANTS
#102N-linked glycan compounds
#103Multi-Target recombination gene and the application of its protein to prevent and cure
#104Vaccine for protection against
#105N-linked glycan compounds
#106Means of controlling infection persistence of
#107Vaccine for protection against and Porcine circo virus
#108Method of preventing early infections
#109Vaccine and methods to reduce campylobacter infection
#110Campylobacter polypeptides and methods of use
#111Vaccine for protection against
#112FREE HEXASACCHARIDE ISOLATED FROM SEVERAL CAMPYLOBACTER SPECIES
#113Secreted flaggella coregulated proteins as immunogens
#114Immune compositions for treating H. pylori infection
#115lipopolysaccharide outer core epitope
#116Antigen compositions and methods of inhibiting bacterial infection and uses of the antigen compositions
#117lipopolysaccharide outer core epitope
#118VACCINATION FOR LAWSONIA INTRACELLULARIS
#119Strains of and uses thereof
#120Oral Vaccines for Producing Mucosal Immunity
#121IMMUNOGEN AGAINST CAMPYLOBACTER INFECTION
#122In ovo vaccination of in avian species
#123presenting N-glycan or derivatives thereof
#124Compositions Produced Using Enteric Pathogens and Methods of Use
#125Antibody to cytolethal distending toxin of
#126Capsule composition for use as immunogen against
#127Helicobacter system and uses thereof
#128vaccines
#129Oral recombinant vaccine and preparing method thereof
#130bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel serotype and hybridomas for producing the said antibodies
#131Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#132IMMUNOGEN AGAINST CAMPYLOBACTER INFECTION
#133VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS
#134VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARS
#135Method of preventing early infections
#136EFFECTIVE METHOD OF TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS
#137Compositions produced using enteric pathogens and methods of use
#138Campylobacter Vaccines and Methods of use
#139Vaccination for
#140Method for treating infections
#141species and cultivation thereof
#142NON-TOXIC MUTANTS OF PATHOGENIC GRAM-NEGATIVE BACTERIA
#143system and uses thereof
#144LAWSONIA PROTEIN USEFUL AS A COMPONENT IN SUBUNIT VACCINE AND METHODS OF MAKING AND USING THEREOF
#145Helicobacter Pylori Vaccination
#146Hydrogenase deficient bacterial strains
#147VACCINES AND METHODS FOR TREATMENT OR PREVENTION OF GRAM NEGATIVE BACTERIAL INFECTION IN A VERTEBRATE SUBJECT
#148Capsule composition for use as immunogen against
#149Novel recombinant T4 phage particle containing HIV, H. pylori or cancer antigens and uses thereof
#150Vaccines for immunization against helicobacter
#151VACCINATION OF HORSES AGAINST LAWSONIA INTRACELLULARIS
#152of european origin and vaccines, diagnostic agents and methods of use thereof
#153METHOD FOR INDUCING MUCOSAL HUMORAL AND CELL-MEDIATED IMMUNE RESPONSES BY SUBLINGUAL ADMINISTRATION OF ANTIGENS
#154Immunological combination compositions and methods
#155Vaccination of young animals against infections
#156Secreted flagella coregulated proteins as immunogens
#157Helicobacter pylori proteins useful for vaccines and diagnostics
#158Lawsonia Intracellularis 26 Kd Subunit Vaccine
#159Surface-located campylobacter jejuni polypeptides
#160Methods for preventing cattle reproductive diseases
#161Methods for preventing cattle reproductive diseases
#162Ovo vaccination of in avian species
#163Non-toxic mutants of pathogenic gram-negative bacteria
#164Helicobacter proteins and vaccines
#165Immunogenic capsule composition for use as a vaccine component against
#166Non-toxic mutants of pathogenic gram-negative bacteria
#167Methods for treating, preventing and diagnosing Helicobacter infection
#168Porcine infection
#169Lawsonia vaccine and methods of use thereof
#170Vaccines for immunization against
#171Use of bdellovibrionaceae as an antimicrobial agent
#172Immunogenic compositions comprising
#173Vaccines for proliferative ileitis and methods of making and using the same
#174Campylobacter glycans and glycopeptides
#175DCchol in newborns
#176High affinity receptors for helicobacter pylori and use thereof
#177Immunological combination compositions and methods
#178Helicobacter system and uses thereof
#179Antigen library immunization
#180Porcine circovirus and Helicobacter combination vaccines and methods of use
#181Compositions produced using enteric pathogens and methods of use
#182Helicobacter pylori vaccination
#183H. pylori FlbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori FlbA polypeptides, and compositions for detection of an infection comprising H. pylori FlbA polypeptides
#184Polysaccharides of
#185Methods of monitoring immunization
#186polypeptides and methods of use
#187Compositions, test kits and methods for detecting helicobacter pylori
#188Non-toxic mutants of pathogenic gram-negative bacteria
#189of European origin and vaccines, diagnostic agents and methods of use thereof